The content on this site is intended for healthcare professionals only
Dr Elias Jabbour speaks to ecancer in online video interview about the management and treatment of patients with acute lymphoblastic leukaemia (ALL) during the COVID-19 pandemic.
He emphasises that patient care and life-saving treatments should not be compromised during the pandemic as this population of patients are highly curable.
Dr Jabbour outlines some examples of how treatment practices have been amended to minimise the risk of COVID-19 for patients with ALL.
ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Synthetic biology and precision medicine in blood and gynaecological cancers
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for August 25th - 31st, 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
Choosing wisely in multiple myeloma
